There’s no doubt. WES must be performed.
Rapidly.
As soon as possible.
The diagnosis is genetic.
We need to know what it is.
Every day may have consequences.
Every treatment becomes navigation by sight.
Prognosis becomes increasingly uncertain, while parental anxiety quietly grows.
Every new symptom brings new questions.
And new worries.
The diagnosis seems to drift further and further away.
But what if we could start immediately?
Conventional whole exome sequencing
is typically measured in weeks, not days.
In Neonatal Intensive Care Units (NICUs) and selected prenatal settings,
even those weeks may influence clinical management.
What if the same clinical answer could be delivered in just 5 days?
5 DAYS
Whole Exome Sequencing (Solo or Trio).
From Sample to Clinical Report.
This is EXOME ULTRA-FAST.
Whole exome sequencing, for solo or trio analyses, re-engineered for clinical urgency.
Time, bent around clinical needs.
72 hours for sequencing. 48 hours for bioinformatics, clinical interpretation and reporting.
Weeks become days.
About this insight
This Industrial Insight explores the role of rapid whole exome sequencing (WES) when time becomes a critical clinical variable, including applications in neonatal intensive care (NICU), prenatal medicine, and other urgent diagnostic scenarios.
To learn more about our Ultra-Fast Workflows, explore our dedicated service page. Understand the principles behind our rare disease diagnostic solutions, including Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), and our complete portfolio of genetic tests.
→ Explore EXOME ULTRA-FAST
→ Whole Exome Sequencing (WES)
→ Whole Genome Sequencing (WGS)
→ Explore our Test Portfolio